Jonathan P. Gertler, MD
Co-founder, Managing Partner and CEO

JONATHAN P. GERTLER, MD, Managing Partner and CEO of Back Bay Life Science Advisors, has over 30 years of clinical, scientific, and business experience with public and private life science companies in many fields, from diagnostics and medical devices to health care IT. A former vascular surgeon and founder of several life science companies, Dr. Gertler is a frequent speaker and writer on strategic issues facing life science companies at all stages.

Before founding Back Bay in 2010, Dr. Gertler served as Senior Partner and Managing Director of Leerink Swann Strategic Advisors and Head of BioPharma Investment Banking at Leerink Swann & Company, as well as Head of Life Science Investment Banking at Adams Harkness/Canaccord Adams.

As consultant, Dr. Gertler has advised companies on growth and liquidity strategies and has been responsible for significant aggregate consideration in M&A, private investment, and public equity for biotech, medtech, and HCIT companies

Dr. Gertler has founded three companies: Antyllus Therapeutics, a development-stage biotechnology company focused on aortic diseases; Biofeedback Systems Design, a healthcare IT company meeting the needs of the wellness market; and Cardiovascular Technologies, which successfully exited in 2001 and is now a part of Boston Scientific. Prior to his advisory and consulting career, he was a Venture Partner at SV Life Sciences from 1997-2001.

An academic vascular surgeon before turning from the operating room to the boardroom, Dr. Gertler was Associate Professor of Surgery at Harvard Medical School and the Massachusetts General Hospital. He has published extensively in clinical vascular surgery and endothelial and smooth muscle cell biology, and has served as an ad-hoc editor for The New England Journal of Medicine, The Journal of Vascular Surgery, The Journal of Critical Care Medicine and Surgery, and others. He currently serves on the Dean’s Advisory Board at Boston University School of Medicine and has been a board member of several private and public companies and non-profit organizations.

Dr. Gertler earned a medical degree from Columbia University College of Physicians and Surgeons, an MBA in Health Policy and Management from Boston University and a BA from Wesleyan University. He is a Fellow of the American College of Surgeons and a member of numerous academic and clinical surgical societies. Dr. Gertler is a Series 24 Registered Securities Principal. He is married with three grown sons and is an avid folk musician, squash player and fly fisherman.

Recent Posts by Jonathan

Managing the EU Capital Gap Toward Successful Investment Outcomes

European life science companies face a relative lack of capital compared to US companies. This gap engenders differing styles of ... Read More

Back Bay Life Science Advisors in the Boston Business Journal

This month, Back Bay CEO, Jonathan P. Gertler, MD, spoke with the Boston Business Journal about the effects on Massachusetts ... Read More

Mentoring the Next Generation of Life Science Innovators

In the life science community, it’s necessary to return to our academic roots to foster knowledge, share learning, and cultivate ... Read More